Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Adult-Onset”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02926937
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 399
Post-approval studies (Phase 4)UnknownNCT05037695
What this trial is testing

SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery DiseaseAcute Kidney Injury
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)Study completedNCT01072331
What this trial is testing

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 99
Large-scale testing (Phase 3)Study completedNCT00976937
What this trial is testing

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 319
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Large-scale testing (Phase 3)Study completedNCT01497522
What this trial is testing

Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 183
Not applicableStudy completedNCT05173675
What this trial is testing

Empathy in Action: Sunshine Calls for Life With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2DiabetesMental Health+1 more
University of Texas at Austin 260
Large-scale testing (Phase 3)Study completedNCT00162240
What this trial is testing

PPAR - Combination With Metformin

Who this might be right for
Diabetes Mellitus
Bristol-Myers Squibb 534
Not applicableStudy completedNCT02754817
What this trial is testing

The Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 611
Large-scale testing (Phase 3)Study completedNCT00111540
What this trial is testing

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 456
Not applicableStudy completedNCT02800668
What this trial is testing

Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusObesity
Ruhr University of Bochum 19
Not applicableUnknownNCT01084850
What this trial is testing

Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects

Who this might be right for
Corneal Dystrophy
Frederiksberg University Hospital 300
Not applicableStudy completedNCT03829891
What this trial is testing

Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Xijing Hospital 60
Post-approval studies (Phase 4)UnknownNCT04559191
What this trial is testing

Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

Who this might be right for
Coronary Atherosclerosis
National Cerebral and Cardiovascular Center, Japan 90
Large-scale testing (Phase 3)Study completedNCT00860288
What this trial is testing

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 1,988
Post-approval studies (Phase 4)Study completedNCT02581488
What this trial is testing

Use of Santyl in Diabetic Foot Ulcers

Who this might be right for
Diabetic FootFoot Ulcer, Diabetic
Smith & Nephew, Inc. 102
Not applicableStudy completedNCT01062048
What this trial is testing

Januvia Re-examination Study (MK-0431-181)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 3,483
Early research (Phase 1)Study completedNCT01065948
What this trial is testing

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

Who this might be right for
Diabetes
BioTex, Inc. 12
Post-approval studies (Phase 4)Study completedNCT03393715
What this trial is testing

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Hypertension
Yaounde Central Hospital 20
Not applicableStudy completedNCT04322240
What this trial is testing

Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy

Who this might be right for
Diabetic PolyneuropathyDiabetes Mellitus, Type 2
Benha University 90
Next Page